RE:RE:RE:RE:RE:RE:RE:Adlai NortyeWhy don't you ask AN what they meant. At least I reached out and got an answer now it's your turn. And how do you know that pfizer could file a bla, you are suggesting to people that you know. AN is a different jursidiction and what they do there should not affect what happens in other jurisdictions. There are drugs that are approved in one jurisdiction but not another.True they said they have no intention to change their direction but at what pace is the big question now. They were supposed to start the phase 3 trial this year and I think IMO that they already have the results of the third cohort as the first 2 were finished very timely and months ago and if continuing on that same timeline and only 3 patients they would have been done already. Also one must remember that according to released docs, onc has a say in the trials so we cannot be sure what part onc is playing in this at this time. A lot of secrecy and behind the scenes, and hopefully maybe just for once the company will be more forthcoming as to what is going on. They have already decided to wait for a major conference for the bracelet results when they stated on multiple occasions that it would be at year end. Does not matter the reason, things are never clear cut with onc and let's hope that this does not get delayed another year.